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and may provide an alternative to surgery in symptomatic patients with 
HOCM. Longer-term follow-up in larger numbem of patients are awaited. 
~ Clinical Significance of LV "Altercontraction" and 
"Contraction Dispersion" by Doppler Tlssuo 
Imaging 
Ra~ G. Pal, Kanwaljit S, Gill. Loma Linda VAMC and Univemity, CA 
Asynchrony in LV relaxation is known to impair global LV function and its 
filling, We investigated the dynamics of LV long axis shortening using pulsed 
wave Doppler tissue imaging in 44 subjects: 10 with normal cardiac anatomy 
(NL), 17 with LV hypertrophy and 17 with semantal wall motion abnormalities 
0NMA). Spectral velocities profiles from medial, lateral, anterior and posterior 
portions of the mitral annulus were recorded from the apical view; their peak 
velocities, durations, and timing to R wave of the ECG and LV ejection were 
measured. Presence of apical motion of the annulus after the end of ejection 
was referred to as LV aftarcontraction and the difference hetween longest 
and shortest durations of the systolic velocities as contra~on dispersion. 
Results: Incidence of aftercontrectien was 1/10 in NL, 12/17 in LVH (p 
< 0.01 vs NL) and 8/17 in WMA (p < 0.05 vs NL) groups. The durations 
of epically directed systolic velocities were similar in all 3 groups, but the 
amplitudes and time velocity integrals were reduced in LVH and WMA. 
The timing of these velocities in relation to the R wave of the ECG were 
marginally prolonged in those with LVH. The contraction dispersion was 40 
4- 23 msec in NL, 53 4- 23 msec in LVH and 45 4- 24 meec in WMA (p 
= 0.06). The transmittal A wave amplitude, but not the NE velocity ratio 
or the LV isovolumic relaxation time was significantly greater in those with 
aftercontractions, 
Conclusions: 1. Amplitudes and timings of the regional mitral annular ve- 
Iocitias are affected by LVH and WMA. 2. LV aftercont,'actions are present 
in LVH and WMA. 3. LV contraction dispersion which is a measure of asyn- 
chronous LV contraction is increased in LVH. 
~ Biopsy-Proven Eoslnophil le Endomyocardlel 
Disease: Survival Analysis  o f  25 Patients 
Elaine M. C. Chau, Lyie J. Olson, William D. Edwards, Gall M. Kuphart, 
Gerald J. Gleich. Mayo Clinic, Rochester, MN 
Eoalnophili¢ endomyocardial disease (EEMD) is a rarely recognized my- 
ocarditls with clinical characteristics tha'L have not been well described. We 
reviewed our experience with biopsy-proven EEMD, including survival analy- 
sis. Biopsy diagnosis was aided by a specific immunoflusrascenca antibody 
method for major basic protein, a cytotoxic protein by-preduct of eoalnophil 
dogrenutation. We identified 26 pts (14 M; 12F) with biepsyd0mvan EEMD 
diagnosed between 1980 and 1994. Pt age ranged from 8-75 yrs (mean 48 
4- 20). EEMD was associated with peripheral eosinuphilia due to idiopathic 
hypereoalnophilic syndrome (HES) (n = 10), atow (n = 7), Churg-Strauss 
syndrome (n = 2), hypersensitivity (n= 2), or unknown (n = 1). Four pts did 
not have peripheral easinophilla. Mean LVEF at diagnosis was 50 4- 19%, 
Twenty-one of 25 pts were treated with immunosuppression comprised of hy- 
droxyurea nd/or corticostemids Morbidity was predominantly due to cardiac 
disease; 22 of 26 pts presented with cardiovascular symptoms, Kaplan-Meler 
survival analysis was performed for 25 of 20 pts (one pt lost to folicw-up). 
Mean follow-up duration was 5.3 4- 4.0 yrs. Five and 10 yr sundval was 60% 
and 42=/0, respectively, signitlcantiy lass than an age- and gender-matched 
control population. Patienis with HES tended to have better surviv~ than 15 
pta with EEMD due to other causes, but tha difference did not reach statistical 
significance (p = 0.09), 
t .  L ,<o=,  
- - - . . .  
0 | 4 | I 10 
Conclusion: Biopsy-proven EEMD is associated with a poor prognosis 
despite immunosuppressien. Pts with EEMD due to HE$ may have a better 
prognosis than pts with EEMD due to other causes. 
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~'~ Dual Inhibition of  Neutral Endopeptidase and 
~og iOtsn~(In Convert ing Enzyme Delays the ress on of  Experimental Heart Failure 
Tracy L Stevens, Daniel D. Borgeson, Margaret M. Redfieid, 
Andreas Luchner, John C. Bumett Jr.. Mayo Clinic, Rochester, MN 
The syndrome of overt conges~ve heart failure (CHF) represents a state 
of cardlomnal decompansation with humorat activation, vasoconstriction, 
sodium retention, and ventdcular remodeling, tne canine model of CHF 
produced by Incremental pacing over 4 weeks, with eaKy and su3tained 
activation of natriuratic peptides and stimulation of vasoconsffictive factors, 
sodium retention and increased left ventncular mass (LVM) we tested the 
hypothesis that potentiation of the vasodilatory nalnuretic peptide system 
(NPS) and attenuation of the renin-angiotsnsin-aldoaterone system (RAAS) 
with combined neutral endopepfidase (NEPI) and angietenaln-converting 
enzyme inhibition (ACEI) (UK81252, Pf'~.er, 10 rag/kg, po bid) would improve 
cardiorenal hemodynemics, odium excretion, and decrease LVM. Compared 
to controldogs (n = 8), UK dege (n = 6) had a greater decrease in MAp (Z~, -36 
4- 4 vs -14 -4- 2 mmHg*) and less increase in systemic vascular resistance ( 
2 4- 3 vs 18 -4- 9 mmHg/IJmln'). Endogenous ANP activation was greater in 
the UK dogs (A 738 4- 63 VS 394 4- 89 pg/mt') together with the suppression 
of aldesterone (4 2 4- 2 vs 30 4- 8 pg/dl'). The onset of sodium retention 
was delayed and at 4 weeks daily sodium excretion was improved (A -17 
+ 9 vs -35 4- 4 mEq/dey') with increased RBF (218 4- 19 vs 118 :J: 20 
ml/min °) and less increase in renal vascular resistance (0.33 4- 0.03 vs 0.77 
4- 0.2") without changes in GFR. The increases in LVM in untreated CHF 
(5.0 4- 0.2 gm/kg) was abolished with treatment with UK (4.0 ± 0.1 gm/kg,) 
(" = p < 0.05). In experimental CHF, pharmacological potentiation of the NPS 
with inh~ition of the RAAS resulted in a delay in the onset and magnitude 
of sodium retsnfion via tubular mechanisms, reduced systemic and renal 
vasoconstriction and abolished increases in LVM. These studies suppo~t a
potential therapeutic action Of NEPI/ACEI in delaying progression to overt 
CHF. 
~ A©ute Heart Failure: A "Relative Brain Natdureti¢ 
Peptide Deficiency State". Functional and 
Therapeutic Implications 
J. Aaron Grenthem, Daniel D. Borgeson, Margaret M. Reolietd, John 
C. Bumett, Jr.. Mayo Clinic Rochester, MN 
The nalduretic peptide system, which includes ANP and BNP, mediates 
tent vasodilatory and natriuretic actions via cGMP. ANP and BNP release 
is differentially regulated in vitro. In vivo BNP is more natTiuretic than ANP. 
The present study tested the hypothesis that in acute heart failure (AHF), 
plasma BNP is not increased despite increased atrial pressure. Secondly, we 
determined the functional significance of "BNP deficiency" by administering 
exogenous BNP in AHF to test the hypothesis that pa~'mphysidlogic concen- 
ITa~ons result In natdureals and reduced cardiac fillI,Io pressures. Two groups 
o! dogs, control (N = 6) and BNP (N = 6), underwent tacbypacthg-lnduced 
AHR Cardioronal and endocrine parameters were analyzed at b~seline (C1), 
in AHF (C2), and dudng BNP (20 ng/kg/min) or saline vehicle infusion (C3). 
Despite elevations in plasma ANP during AHF (42 4-14 vs. 315 4- 83 pg/ml, 
Cl vs, C2, p < 0.05) no natduretic effect was observed (UNaV 30 4- 5 vs. 
9 4- 2 meq/min, Cl vs. C2, p < 0.05). Unlike ANP, BNP was not elevated 
by AHF (32 ± 9 vs. 39 4- 15 pg/ml, Cl vs. C2, p = NS) despite increased 
PCWP (5A 4- 0,3 vs. 12 4- 4.2 mmHg, C1 vs. C2, p < 0.05}. In the BNP 
group, exogenous BNP increased plasma BNP (26 4- 14 vs. 716 4- 123 
pg/ml, C1 vs. C3, p < 0.01) wi~ associated reductions in PCWP (13,1 4-1.3 
vs. 8.8 + 0.9 mmHg, control vs. BNP, p < 0.02) without altedng CO or SVR. 
Elevated circulating BNP produced natriureals (UNaV 20 4- 6 vs. 121 4- 44 
reed/rain, control vs. BNP, p < 0.05) associated with elevations in plasma 
cGMP (17:1:4 vs. 65 + 7 pg/ml, control vs. BNP, p < 0.01) by reducing 
distal tubular fractional reabsorption of so,urn (DFRNa 98.3 4- 0.4 vs, 93.9 
4- 2.1%, control vs. BNP, p < 0.05) with no change in GFR. We conclude that 
ANP and BNP release is differentially regulated in AHF resulting in a state 
of "relative BNP def'ciency". That administration ofBNP results in natriuresie 
by renal tubular actions, and results in reductions in cardiac filling pressures, 
This demonstrates the bidloglo significance of "BNP deficiency" in AHF and 
suggests a therapeutic role for BNP administration i AHF. 
